Arkolith/Insider Trading/IMDX/Form 4/A

James Andrea S.

Chief Financial OfficerInsight Molecular Diagnostics Inc. (IMDX) · full profile →Form 4/A · filed Nov 13, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 31, 2025Tax withholding(F)12K$6.01$73K189K
Oct 31, 2025Option exercise(M)50K—$0201K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 31, 2025Option exercise(M)50K—$050K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001493152-25-022358) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML